November & December 2020
January & February 2021

Online event

Webinar 'Photonics against COVID-19'

Tuesday 24 November
15:00 - 17:00

Arno van de Kant

Spektrax

Title: Beyond COVID-19, multiplatform diagnostics

Abstract

SPEKTRAX is on a mission to scale up production of an ultra-fast COVID-19 test kit so hundreds of thousands of people can regain their freedom and security with an instant test. Since January 2020 we are working on a groundbreaking technology to detect virus particles in patient saliva. Enhanced Raman spectroscopy, nanotechnology coated chips and Ai based software are the core expertise’s we use in order to be able to detect SARS-CoV-2 virus in only 30 seconds measuring time. Our technology enables the identification of single molecules; every molecule giving a particular peak in the Raman spectrum creating a unique and detectable signature. We are therefor able to discriminate the SARS-CoV-2 virus from other viruses like influenza.
We applied our technology to virus particles and discovered that this method is highly specific and sensitive, and ultra-rapid. The measurement itself is 30 seconds max and is processed by a proprietary Machine Learning model for classification. As soon as we have completed the validation and certification (CE-IVD) we want to supply our customers with large quantities of test kits, so they can start with large scale testing. But this is just the starting point of the possibilities of the technology, which will be further developed into a multiplatform diagnostics tool, which can be applied even in remote area’s. Availability and affordability of diagnostics worldwide is our goal.  

Biography

Trained as microbiologist, working in commercial, business development and CEO role’s with 30 years of experience. From large enterprises like AKZO Nobel and BioMerieux to lately mainly startup companies like BPF, NSure and now Spektrax. Experienced in Medical Microbiology and Industrial Biotechnology, with equipment/reagent products but also many contract research organizations like NZIO food research and TNO. Now helping Spektrax to develop and introduce a novel nanotech based technology to simplify microbiology diagnostics, with the aim to make this accessible and affordable.

Company description:

SPEKTRAX is developing a nanotechnology based instant diagnostics platform.
Our test kits will allow for rapid testing (few minutes), anywhere in the world, without expensive and time-consuming lab facilities.
Starting with SARS-CoV-2 (COVID-19) other diagnostics test will follow shortly.